Where does Psomagen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Psomagen, Inc. ranks #9,108 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Psomagen, Inc. hold?

Psomagen, Inc. holds 35 US utility patents granted between 2020 and 2024, spanning 16 technology areas.

What is Psomagen, Inc.'s Innovation Score?

Psomagen, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Psomagen, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Psomagen, Inc..

What does claim depth mean for Psomagen, Inc.'s patents?

Psomagen, Inc.'s patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Psomagen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Psomagen, Inc.

Q: What technology areas does Psomagen, Inc. focus on?

Psomagen, Inc.'s top technology area is G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY) with 30 patents. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 35 granted patents across 16 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Psomagen ranks #9,108 of 50,000 tracked US assignees by granted-patent volume, with 35 patents across 16 technology areas.

#9,108
of 50,000 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 18.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R9108 · US Corporation #9,108 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 35 grants
UPPER-Q #9,108/50,000
PHOTO-FINISH Polymer Technology S…
CPC-FOCUS G16B · 16 areas
INNOV-PAR 40.2/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Polymer Technology Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Applied Micro Circuits · near

40
CAP · near

40
CDE Global · near

40
Psomagen · this assignee

40
Biodesix · near

40
3D Lighting Innovati… · lowest

7

What this shows Psomagen, Inc. stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #9,108 of 50,000; Innovation Score 40.2/100 sits in the top 36% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Polymer Technology Systems, Inc. (±0 grants).

Portfolio overview

Psomagen, Inc. has been granted 35 US utility patents between 2020 and 2024, placing Psomagen, Inc. at #9,108 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY). As a US Corporation, Psomagen, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Psomagen sits between Polymer Technology Systems, Inc. (35 patents, rank #9,103) and Robert Welch Designs Ltd. (35 patents, rank #9,111) - the closest US assignees by grant volume. The composite Innovation Score of 40.2/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2024, with 35 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Psomagen, Inc.'s 18.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 16 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Polymer Technolog…

35
Portland State Un…

35
Profound Medical

35
Project Canary PBC

35
Rijksuniversiteit…

35
Raise Marketplace

35
Reciprocal Labs

35
Robert Welch Desi…

35
Psomagen ◀

35

What this shows Psomagen holds 35 patents at rank #9,107, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Psomagen

By rank, the assignees closest to #9,107 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Psomagen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Psomagen, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (40 here).

CAP Corporation 40 CDE Global Limited 40 Applied Micro Circuits Corporation 40 Biodesix, Inc. 40

Psomagen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Psomagen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	21	60.0%
2021	4	11.4%
2022	1	2.9%
2023	6	17.1%
2024	3	8.6%

Which technologies does Psomagen, Inc. patent most?

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 30

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 27

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 26

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 25

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 3

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 2

C07K - PEPTIDES 1

B03C - MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS 1

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

G16C - COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE 1

G06F - ELECTRIC DIGITAL DATA PROCESSING 1

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#9,108

of 50,000 tracked assignees

Innovation Score

40.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.